Pathology of immune reconstitution inflammatory syndrome in multiple sclerosis with natalizumab-associated progressive multifocal leukoencephalopathy

Acta Neuropathologica

Volumn 123, Issue 2, 2012, Pages 235-245

  Metz, Imke ^a   Radue, Ernst Wilhelm ^b   Oterino, Agustin ^c   Kümpfel, Tania ^d   Wiendl, Heinz ^e   Schippling, Sven ^f   Kuhle, Jens ^b   Sahraian, Mohammad Ali ^g   Gray, Francoise ^h   Jakl, Veronika ^d   Häusler, Darius ^a   Brück, Wolfgang ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^d UNIVERSITY OF MUNICH   (Germany)

^e UNIVERSITY OF MÜNSTER   (Germany)

^f UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^g TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^h HÔPITAL LARIBOISIÈRE   (France)

Author keywords

IRIS; MRI; MS; Natalizumab; Pathology; PML

Indexed keywords

NATALIZUMAB;

ADULT; ARTICLE; BRAIN BIOPSY; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFECT; DRUG SAFETY; FEMALE; GRAY MATTER; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; MACROPHAGE; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PLASMA CELL; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; TREATMENT DURATION; VIRUS INFECTION; WHITE MATTER;

ADULT; ANTIBODIES, MONOCLONAL, HUMANIZED; FEMALE; HUMANS; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; SYNDROME;

EID: 84857030535     PISSN: 00016322     EISSN: 14320533     Source Type: Journal    
DOI: 10.1007/s00401-011-0900-5     Document Type: Article

References (28)

1. JR Berger 2010 Progressive multifocal leucoencephalopathy and newer biological agents Drug Saf 33 969 983 20925435 10.2165/11537510-000000000-00000 1:CAS:528:DC%2BC3cXhsFaktrjI
2. DB Clifford LA De DM Simpson G Arendt G Giovannoni A Nath 2010 Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases Lancet Neurol 9 438 446 20298967 10.1016/S1474-4422(10)70028-4 1:CAS:528:DC%2BC3cXltF2ktLg%3D
3. RA Du Pasquier MJ Kuroda Y Zheng J Jean-Jacques NL Letvin IJ Koralnik 2004 A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy Brain 127 1970 1978 15215217 10.1093/brain/awh215 (Pubitemid 39150256)
4. B Engelhardt L Kappos 2008 Natalizumab: targeting alpha4-integrins in multiple sclerosis Neurodegener Dis 5 16 22 18075270 10.1159/000109933 1:CAS:528:DC%2BD2sXhsVanur3O (Pubitemid 350261811)
5. J Gasnault M Kahraman MG de Herve D Durali JF Delfraissy Y Taoufik 2003 Critical role of JC virus-specific CD4 T-cell responses in preventing progressive multifocal leukoencephalopathy AIDS 17 1443 1449 12824781 10.1097/00002030-200307040-00004 (Pubitemid 36900544)
6. SA Kalams BD Walker 1998 The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses J Exp Med 188 2199 2204 9858506 10.1084/jem.188.12.2199 1:CAS:528:DyaK1MXhtFaruw%3D%3D (Pubitemid 29028492)
7. N Khanna M Wolbers NJ Mueller C Garzoni RA Du Pasquier CA Fux P Vernazza E Bernasconi R Viscidi M Battegay HH Hirsch 2009 JC virus-specific immune responses in human immunodeficiency virus type 1 patients with progressive multifocal leukoencephalopathy J Virol 83 4404 4411 19211737 10.1128/JVI.02657-08 1:CAS:528:DC%2BD1MXlt1Kqu7g%3D
8. BO Khatri S Man G Giovannoni AP Koo J-C Lee B Tucky G Lyon S Jurgensen J Woodworth S Goelz PW Duda MA Panzara RM Ransohoff RJ Fox 2009 Effect of plasma exchange in accelerating natalizumab clearance and restoring leukocyte function Neurology 72 402 409 19188571 10.1212/01.wnl.0000341766.59028.9d 1:CAS:528:DC%2BD1MXhtVClu70%3D
9. IJ Koralnik RA Du Pasquier NL Letvin 2001 JC virus-specific cytotoxic T lymphocytes in individuals with progressive multifocal leukoencephalopathy J Virol 75 3483 3487 11238876 10.1128/JVI.75.7.3483-3487.2001 1:CAS:528: DC%2BD3MXitVGhsrg%3D (Pubitemid 32225913)
10. M Krumbholz I Meinl T Kumpfel R Hohlfeld E Meinl 2008 Natalizumab disproportionately increases circulating pre-B and B cells in multiple sclerosis Neurology 71 1350 1354 18936427 10.1212/01.wnl.0000327671.91357.96 1:CAS:528:DC%2BD1cXht1Ggu7%2FI
11. Kuhle J, Gosert R, Bühler R, Derfuss T, Sutter R, Yaldizli Ö, Radue E-W, Ryschkewitsch C, Major EO, Kappos L, Frank S, Hirsch HH (2011) Management and outcome of CSF-JC virus PCR-negative PML in a natalizumab-treated MS patient. Neurology (in press)
12. T Lenhard A Biller W Mueller I Metz J Schonberger B Wildemann 2010 Immune reconstitution inflammatory syndrome after withdrawal of natalizumab? Neurology 75 831 833 20805529 10.1212/WNL.0b013e3181f07362 1:STN:280: DC%2BC3cjosFOqtA%3D%3D
13. C Lucchinetti W Brück J Parisi B Scheithauer M Rodriguez H Lassmann 2000 Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination Ann Neurol 47 707 717 10852536 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q 1:STN:280:DC%2BD3czgvFektA%3D%3D (Pubitemid 30390191)
14. EO Major 2009 Reemergence of PML in natalizumab-treated patients-new cases, same concerns N Engl J Med 361 1041 1043 19741226 10.1056/NEJMp0906248 1:CAS:528:DC%2BD1MXhtFalt7fO
15. P Miralles J Berenguer C Lacruz J Cosin JC Lopez B Padilla L Munoz D Garcia-de-Viedma 2001 Inflammatory reactions in progressive multifocal leukoencephalopathy after highly active antiretroviral therapy AIDS 15 1900 1902 11579261 10.1097/00002030-200109280-00028 1:STN:280:DC%2BD3MrjtFyrtA%3D%3D (Pubitemid 32939260)
16. AM Munoz-Marmol G Mola A Fernandez-Vasalo E Vela JL Mate A Ariza 2004 JC virus early protein detection by immunohistochemistry in progressive multifocal leukoencephalopathy: a comparative study with in situ hybridization and polymerase chain reaction J Neuropathol Exp Neurol 63 1124 1130 15581180 1:CAS:528:DC%2BD2cXhtVOqt7bF (Pubitemid 39492018)
17. CH Polman PW O'Connor E Havrdova M Hutchinson L Kappos DH Miller JT Phillips FD Lublin G Giovannoni A Wajgt M Toal F Lynn MA Panzara AW Sandrock 2006 A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis N Engl J Med 354 899 910 16510744 10.1056/NEJMoa044397 1:CAS:528:DC%2BD28XitVertL4%3D
18. EP Richardson Jr PC Johnson 1975 Atypical progressive multifocal leukoencephalopathy with plasma-cell infiltrates Acta Neuropathol Suppl 6 247 250 1057843
19. A Safdar RJ Rubocki JA Horvath KK Narayan RL Waldron 2002 Fatal immune restoration disease in human immunodeficiency virus type 1-infected patients with progressive multifocal leukoencephalopathy: impact of antiretroviral therapy-associated immune reconstitution Clin Infect Dis 35 1250 1257 12410486 10.1086/344056 (Pubitemid 35305874)
20. Sandrock A et al (2011) American Academy of Neurology Annual Meeting 2011, Poster-AAN B03.248, Honolulu, Hawai, 21-28 April 2011
21. Schwab N, Hohn KG, Schneider-Hohendorf T, Metz I, Stenner MP, Jilek S, Du Pasquier RA, Gold R, Meuth SG, Ransohoff RM, Bruck W, Wiendl H (2011) Immunological and clinical consequences of treating a patient with natalizumab. Mult Scler (in press)
22. R Shah AK Bag PR Chapman JK Cure 2010 Imaging manifestations of progressive multifocal leukoencephalopathy Clin Radiol 65 431 439 20451009 10.1016/j.crad.2010.03.001 1:STN:280:DC%2BC3czisV2nuw%3D%3D
23. IL Tan JC McArthur DB Clifford EO Major A Nath 2011 Immune reconstitution inflammatory syndrome in natalizumab-associated PML Neurology 77 1061 1067 21832229 10.1212/WNL.0b013e31822e55e7 1:CAS:528:DC%2BC3MXhtFOmurjL
24. Tysabri (2011) Corporate website. http://tysabri.de/index.php?inhalt= tysabri.pmlinzidenz
25. A Vendrely B Bienvenu J Gasnault JB Thiebault D Salmon F Gray 2005 Fulminant inflammatory leukoencephalopathy associated with HAART-induced immune restoration in AIDS-related progressive multifocal leukoencephalopathy Acta Neuropathol 109 449 455 15739098 10.1007/s00401-005-0983-y 1:CAS:528: DC%2BD2MXjvF2ntL8%3D (Pubitemid 40637320)
26. T Weber C Trebst S Frye P Cinque L Vago CJ Sindic WJ Schulz-Schaeffer HA Kretzschmar W Enzensberger G Hunsmann W Luke 1997 Analysis of the systemic and intrathecal humoral immune response in progressive multifocal leukoencephalopathy J Infect Dis 176 250 254 9207375 10.1086/514032 1:STN:280:DyaK2szltV2quw%3D%3D (Pubitemid 27272877)
27. W Wenning A Haghikia J Laubenberger DB Clifford PF Behrens A Chan R Gold 2009 Treatment of progressive multifocal leukoencephalopathy associated with natalizumab N Engl J Med 361 1075 1080 19741228 10.1056/NEJMoa0810257 1:CAS:528:DC%2BD1MXhtFartr3M
28. TA Yousry EO Major C Ryschkewitsch G Fahle S Fischer J Hou B Curfman K Miszkiel N Mueller-Lenke E Sanchez F Barkhof EW Radue HR Jager DB Clifford 2006 Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy N Engl J Med 354 924 933 16510746 10.1056/NEJMoa054693 1:CAS:528:DC%2BD28XitVertLs%3D